IFN{gamma} mediates the resistance of tumor cells to distinct NK cell subsets
Background
Immune checkpoint blockade targeting the adaptive immune system has revolutionized the treatment of cancer. Despite impressive clinical benefits observed, patient subgroups remain non-responsive underscoring the necessity for combinational …